1
/
of
1
Elabscience
SKU:E-CL-R0069
Rat BCL-2(B-Cell Leukemia/Lymphoma 2) CLIA Kit
Rat BCL-2(B-Cell Leukemia/Lymphoma 2) CLIA Kit
Regular price
$682.00 USD
Regular price
Sale price
$682.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Rat BCL-2 (B-Cell Leukemia/Lymphoma 2) CLIA Kit, a cutting-edge laboratory tool designed to facilitate accurate and efficient analysis of BCL-2 protein levels in rat samples. This comprehensive kit is meticulously crafted to meet the highest standards of quality and reliability, ensuring precise and reproducible results.
The Rat BCL-2 CLIA Kit is specifically engineered for researchers and scientists working in the field of oncology, enabling them to investigate the role of BCL-2 in B-cell leukemia and lymphoma. With its advanced chemiluminescent immunoassay (CLIA) technology, this kit offers exceptional sensitivity and specificity, allowing for the detection and quantification of BCL-2 protein with utmost precision.
This state-of-the-art kit includes all the necessary components for a seamless experimental workflow, including microplates, reagents, and controls. The microplates are pre-coated with highly specific antibodies, ensuring optimal capture of BCL-2 protein. The reagents provided are meticulously formulated to deliver consistent and reliable results, while the controls serve as valuable references for accurate interpretation of experimental data.
The Rat BCL-2 CLIA Kit boasts several key features that set it apart from conventional methods. Its wide dynamic range enables the detection of BCL-2 protein across a broad concentration spectrum, accommodating diverse experimental requirements. Additionally, the kit offers excellent assay precision, minimizing variability and enhancing the reliability of results.
With its user-friendly protocol, the Rat BCL-2 CLIA Kit simplifies the experimental process, making it accessible to researchers of varying expertise levels. The kit's comprehensive instructions guide users through each step, ensuring optimal performance and minimizing the risk of errors.
In summary, the Rat BCL-2 CLIA Kit is a sophisticated and reliable laboratory tool that empowers researchers to delve into the intricate mechanisms of B-cell leukemia and lymphoma. Its exceptional sensitivity, specificity, and ease of use make it an indispensable asset in the pursuit of scientific advancements in the field of oncology.
The Rat BCL-2 CLIA Kit is specifically engineered for researchers and scientists working in the field of oncology, enabling them to investigate the role of BCL-2 in B-cell leukemia and lymphoma. With its advanced chemiluminescent immunoassay (CLIA) technology, this kit offers exceptional sensitivity and specificity, allowing for the detection and quantification of BCL-2 protein with utmost precision.
This state-of-the-art kit includes all the necessary components for a seamless experimental workflow, including microplates, reagents, and controls. The microplates are pre-coated with highly specific antibodies, ensuring optimal capture of BCL-2 protein. The reagents provided are meticulously formulated to deliver consistent and reliable results, while the controls serve as valuable references for accurate interpretation of experimental data.
The Rat BCL-2 CLIA Kit boasts several key features that set it apart from conventional methods. Its wide dynamic range enables the detection of BCL-2 protein across a broad concentration spectrum, accommodating diverse experimental requirements. Additionally, the kit offers excellent assay precision, minimizing variability and enhancing the reliability of results.
With its user-friendly protocol, the Rat BCL-2 CLIA Kit simplifies the experimental process, making it accessible to researchers of varying expertise levels. The kit's comprehensive instructions guide users through each step, ensuring optimal performance and minimizing the risk of errors.
In summary, the Rat BCL-2 CLIA Kit is a sophisticated and reliable laboratory tool that empowers researchers to delve into the intricate mechanisms of B-cell leukemia and lymphoma. Its exceptional sensitivity, specificity, and ease of use make it an indispensable asset in the pursuit of scientific advancements in the field of oncology.
Share
